Perceiving the Concealed and Unreported Pharmacophoric Features of the 5-Hydroxytryptamine Receptor Using Balanced QSAR Analysis

The 5-hydroxytryptamine receptor 6 (5-HT6) has gained attention as a target for developing therapeutics for Alzheimer’s disease, schizophrenia, cognitive dysfunctions, anxiety, and depression, to list a few. In the present analysis, a larger and diverse dataset of 1278 molecules covering a broad che...

Descripción completa

Detalles Bibliográficos
Autores principales: Bukhari, Syed Nasir Abbas, Elsherif, Mervat Abdelaziz, Junaid, Kashaf, Ejaz, Hasan, Alam, Pravej, Samad, Abdul, Jawarkar, Rahul D., Masand, Vijay H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316833/
https://www.ncbi.nlm.nih.gov/pubmed/35890133
http://dx.doi.org/10.3390/ph15070834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316833/
https://www.ncbi.nlm.nih.gov/pubmed/35890133
http://dx.doi.org/10.3390/ph15070834

Ejemplares similares